Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.
Journal: Diabetes research and clinical practice
Published: August 20, 2025
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 11, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026